Characteristics of Persistent Symptoms Manifested after SARS-CoV-2 Vaccination: An Observational Retrospective Study in a Specialized Clinic for Vaccination-Related Adverse Events. — CFSMEATLAS
Characteristics of Persistent Symptoms Manifested after SARS-CoV-2 Vaccination: An Observational Retrospective Study in a Specialized Clinic for Vaccination-Related Adverse Events.
Tokumasu, Kazuki, Fujita-Yamashita, Manami, Sunada, Naruhiko et al. · Vaccines · 2023 · DOI
Quick Summary
Researchers at a specialized clinic in Japan studied 121 patients who experienced long-lasting symptoms after receiving a COVID-19 vaccine. The most common symptoms were numbness or tingling sensations (28% of patients), extreme tiredness (25%), fever (17%), and headaches (17%). Some patients developed serious conditions including ME/CFS, and most symptoms started within a week of vaccination but lasted months or longer.
Why It Matters
This study is relevant to ME/CFS patients because it identified ME/CFS as a serious complication in a subset of vaccination-related adverse event clinic patients, and characterizes a cohort experiencing prolonged fatigue and neurological symptoms. For researchers, it provides clinical descriptors of post-vaccination persistent symptoms that may inform case definitions and phenotyping in investigation of potential post-vaccination ME/CFS cases.
Observed Findings
Sensory impairment (numbness/tingling) was the most frequent persistent symptom (28.1% of patients)
General fatigue occurred in 24.8% of patients, with cases meeting ME/CFS criteria identified
Symptom onset ranged from 12 hours to one week post-vaccination
Ten patients experienced symptoms persisting for 6 months or longer
Six patients had serious complications requiring corticosteroid treatment, including ME/CFS, sarcoidosis, aseptic meningitis, and NMOSD
Inferred Conclusions
Persistent neurological and systemic symptoms can manifest following SARS-CoV-2 vaccination in a proportion of patients seeking specialized evaluation
ME/CFS may rarely occur in temporal association with vaccination, though causality remains unestablished
Sensory disturbances represent the most common persistent symptom phenotype in this clinic population
Remaining Questions
What is the actual incidence of these persistent symptoms in the broader vaccinated population, and do they occur at elevated rates compared to unvaccinated controls?
What are the pathophysiological mechanisms underlying the observed symptoms, and can they be linked to vaccine components or immune responses?
What This Study Does Not Prove
This study does not establish causation between SARS-CoV-2 vaccination and the documented symptoms or conditions; the authors explicitly state causal relationships were not determined. The lack of control groups, baseline comparison data, and population denominators prevents assessment of whether these symptoms occurred at rates higher than expected in the general population. Some symptoms may have coincidental onset rather than causal relationship to vaccination.